2027 SPEAKERS

Eunice Alvazzi, Global Head, Hematology, Nephrology, Transplant & Neurology, Access & Pricing, Alexion – AstraZeneca Rare Disease

Eunice Alvazzi | Global Head, Hematology, Nephrology, Transplant & Neurology, Access & Pricing | Alexion – AstraZeneca Rare Disease » speaking at World EPA Congress

Marta Andreykiv, Global Market Access, Viatris

Marta Andreykiv | Global Market Access | Viatris » speaking at World EPA Congress

Ad Antonisse, Director, Market Access & Corporate Affairs, AstraZeneca

Ad Antonisse | Director, Market Access & Corporate Affairs | AstraZeneca » speaking at World EPA Congress

Jorge Arellano, Senior Vice President, Global Head PAVE, Pricing, Access, Value & Evidence, BioMarin

Jorge Arellano | Senior Vice President, Global Head PAVE, Pricing, Access, Value & Evidence | BioMarin » speaking at World EPA Congress

Alex Bastian, Vice President, Commercial Strategy, Memo Therapeutics

Katja Berg, Global Director, Innovative Value and Access Strategy, Global Market Access and Pricing, BBU, AstraZeneca

Katja Berg | Global Director, Innovative Value and Access Strategy, Global Market Access and Pricing, BBU | AstraZeneca » speaking at World EPA Congress

Thomas Bols, Head of Government Affairs and Patient Advocacy, EMEA & APAC, PTC Therapeutics

Thomas Bols | Head of Government Affairs and Patient Advocacy, EMEA & APAC | PTC Therapeutics » speaking at World EPA Congress

Pedro Borga, Regional Market Access and Pricing Director, Amicus Therapeutics

Pedro Borga | Regional Market Access and Pricing Director | Amicus Therapeutics » speaking at World EPA Congress

Okke-Jaap Bosgra, Director International Market Access, Natera

Okke-Jaap Bosgra | Director International Market Access | Natera » speaking at World EPA Congress

Vidya Breeveld, founder & CEO, Transmineo

Vidya Breeveld | founder & CEO | Transmineo » speaking at World EPA Congress

Thomas Broekhoff, Program Manager Medicines, hollandbio

Thomas Broekhoff | Program Manager Medicines | hollandbio » speaking at World EPA Congress

Henriette Burghoorn, Associate Director, Market Access, Gilead Sciences

Henriette Burghoorn | Associate Director, Market Access | Gilead Sciences » speaking at World EPA Congress

Antonella Cardone, CEO, Cancer Patients Europe

Antonella Cardone | CEO | Cancer Patients Europe » speaking at World EPA Congress

Lamis Chahoud, Head of Access & Pricing Region New Markets, BeOne Medicines

Lamis Chahoud | Head of Access & Pricing Region New Markets | BeOne Medicines » speaking at World EPA Congress

Sally Chung, Vice President, Value & Access International Operations & Excellence, Ipsen

Sally Chung | Vice President, Value & Access International Operations & Excellence | Ipsen » speaking at World EPA Congress

Marie-Monique de Molliens, Global Market Access Horizon Scanning Senior Director, Sanofi

Marie-Monique de Molliens | Global Market Access Horizon Scanning Senior Director | Sanofi » speaking at World EPA Congress

Eva Susanne Dietrich, Professor, Departments for Clinical Pharmacy and Regulatory Affairs, University of Bonn

Eva Susanne Dietrich | Professor, Departments for Clinical Pharmacy and Regulatory Affairs | University of Bonn » speaking at World EPA Congress

Toon Digneffe, Head Public Affairs & Public Policy, Takeda

Riad Dirani, Vice President, Global Health Economics, Value and Outcomes, Teva Pharmaceuticals

Riad Dirani | Vice President, Global Health Economics, Value and Outcomes | Teva Pharmaceuticals » speaking at World EPA Congress

Marcus Droege, Executive Vice President, Managing Director, Pharmaconcepts

Marcus Droege | Executive Vice President, Managing Director | Pharmaconcepts » speaking at World EPA Congress

Marieangela Economopoulou, Head of External Affairs and Patient Value Access - Greece, Cyprus, Malta, Takeda Hellas

Marieangela Economopoulou | Head of External Affairs and Patient Value Access - Greece, Cyprus, Malta | Takeda Hellas » speaking at World EPA Congress

Maria Eriksson, Medical Assessor, Ph D., TLV

Maria Eriksson | Medical Assessor, Ph D. | TLV » speaking at World EPA Congress

Stefaan Fiers, Chapter Head, External Affairs, Roche

Stefaan Fiers | Chapter Head, External Affairs | Roche » speaking at World EPA Congress

Steven Flostrand, Executive Director, Value, Access & Pricing, Incyte Corp.

Steven Flostrand | Executive Director, Value, Access & Pricing | Incyte Corp. » speaking at World EPA Congress

Katie Gardner, Global Head of Market Access Excellence & Capabilities, Astellas

Katie Gardner | Global Head of Market Access Excellence & Capabilities | Astellas » speaking at World EPA Congress

Brad Groves, Associate Director, Managed Access, National Institute for Health & Care Excellence (NICE)

Brad Groves | Associate Director, Managed Access | National Institute for Health & Care Excellence (NICE) » speaking at World EPA Congress

Marlene Gyldmark, EU HTA lead, BeOne Medicines

Marlene Gyldmark | EU HTA lead | BeOne Medicines » speaking at World EPA Congress

Amy Israel, Senior Advisor, Access to Medicines, Union for International Cancer Control

Amy Israel | Senior Advisor, Access to Medicines | Union for International Cancer Control » speaking at World EPA Congress

Sophie Janssens, Sr VP, Global Head of Patient Impact Maximization (GO), UCB

Sophie Janssens | Sr VP, Global Head of Patient Impact Maximization (GO) | UCB » speaking at World EPA Congress

Madhu Kabra, Global Director, HEOR, MKGlobal

Madhu Kabra | Global Director, HEOR | MKGlobal » speaking at World EPA Congress

Sven Klijn, Director, HEOR Evidence Acceleration & Innovation, Bristol Myers Squibb

Sven Klijn | Director, HEOR Evidence Acceleration & Innovation | Bristol Myers Squibb » speaking at World EPA Congress

Jolanda Koenders, Head lx, Takeda

Jolanda Koenders | Head lx | Takeda » speaking at World EPA Congress

Nick Leach, Founder, Red Thread Market Access Ltd

Nick Leach | Founder | Red Thread Market Access Ltd » speaking at World EPA Congress

Charles Makin, Head of US Real World Evidence & Epidemiology, Boehringer Ingelheim

Charles Makin | Head of US Real World Evidence & Epidemiology | Boehringer Ingelheim » speaking at World EPA Congress

Bill Malcolm, Executive Director, Global HEOR Economic & Predictive Modelling, Bristol Myers Squibb

Bill Malcolm | Executive Director, Global HEOR Economic & Predictive Modelling | Bristol Myers Squibb » speaking at World EPA Congress

Marco Marchetti, Co-Chair, HTA Coordination Group & Director, Health Technology Assessment Unit, European Commission & National Agency for Regional Care Services, Italy

Marco Marchetti | Co-Chair, HTA Coordination Group & Director, Health Technology Assessment Unit | European Commission & National Agency for Regional Care Services, Italy » speaking at World EPA Congress

Silvy Mardiguian, Head of HEOR, Europe & New Markets, BeOne Medicines

Silvy Mardiguian | Head of HEOR, Europe & New Markets | BeOne Medicines » speaking at World EPA Congress

Sandra Margunato Debay, Executive Director, Global Value, Access and Pricing, Revolution Medicines

Sandra Margunato Debay | Executive Director, Global Value, Access and Pricing | Revolution Medicines » speaking at World EPA Congress

Emanuele Marsili, Global Access Director, CSL

Emanuele Marsili | Global Access Director | CSL » speaking at World EPA Congress

Alessandro Monaco, General Manager, Oliba Healthcare and Pharma

Alessandro Monaco | General Manager | Oliba Healthcare and Pharma » speaking at World EPA Congress

Santiago Moreno, Global Head HEOR, Menarini

Santiago Moreno | Global Head HEOR | Menarini » speaking at World EPA Congress

Gorden Muduma, Senior Director Market Access -EMEA Region, Orchard Therapeutics

Gorden Muduma | Senior Director Market Access -EMEA Region | Orchard Therapeutics » speaking at World EPA Congress

Funmi Oluwa, Head of Market Access & External Engagement, UCB Pharma

Funmi Oluwa | Head of Market Access & External Engagement | UCB Pharma » speaking at World EPA Congress

Gianfranco Parlato, Global Head of Value Access, Pricing & Policy CMVD (CardioMetabolism & Venous Diseases), Servier International

Gianfranco Parlato | Global Head of Value Access, Pricing & Policy CMVD (CardioMetabolism & Venous Diseases) | Servier International » speaking at World EPA Congress

Peter Pemberton-Ross, Head, HE & HTA Strategy, Biogen International GmbH

Peter Pemberton-Ross | Head, HE & HTA Strategy | Biogen International GmbH » speaking at World EPA Congress

Uffe Ploug, Global Health Economics Director, UCB

Uffe Ploug | Global Health Economics Director | UCB » speaking at World EPA Congress

Annette Powers, Senior Vice President, Global Access & Value and Public Policy (GAVP), Astellas

Annette Powers | Senior Vice President, Global Access & Value and Public Policy (GAVP) | Astellas » speaking at World EPA Congress

Sonia Pulido Sánchez, Co-Chair of the Subgroup for Joint Scientific Consultations of the HTACG, AEMPS

Sonia Pulido Sánchez | Co-Chair of the Subgroup for Joint Scientific Consultations of the HTACG | AEMPS » speaking at World EPA Congress

Sandra Rose, Head of Market Access & Public Affairs, Chiesi

Sandra Rose | Head of Market Access & Public Affairs | Chiesi » speaking at World EPA Congress

Charlotte Roy, Life Sciences Policy and Influencing Manager, The Muscular Dystrophy U.K.

Charlotte Roy | Life Sciences Policy and Influencing Manager | The Muscular Dystrophy U.K. » speaking at World EPA Congress

Noem Sain, EU Market Access Lead, UCB Pharma

Noem Sain | EU Market Access Lead | UCB Pharma » speaking at World EPA Congress

Steve Sandor, Vice President, Market Access, Trade and Government Affairs, Paratek Pharmaceuticals , Inc.

Steve Sandor | Vice President, Market Access, Trade and Government Affairs | Paratek Pharmaceuticals , Inc. » speaking at World EPA Congress

Manoj Sood, Commercial Access Director, Independent Market Access Expert

Manoj Sood | Commercial Access Director | Independent Market Access Expert » speaking at World EPA Congress

Jan Swiderski, Head of Government Affairs & Policy, Kyowa Kirin International

Jan Swiderski | Head of Government Affairs & Policy | Kyowa Kirin International » speaking at World EPA Congress

Elena Tricca, Vice President, Global Market Access and Pricing, BioPharmaceuticals, AstraZeneca

Elena Tricca | Vice President, Global Market Access and Pricing, BioPharmaceuticals | AstraZeneca » speaking at World EPA Congress

Stine Trolle, Senior Advisor, Danish Medicines Agency (DKMA)

Stine Trolle | Senior Advisor | Danish Medicines Agency (DKMA) » speaking at World EPA Congress

Sheela Upadhyaya, Life Science Advisor in Rare Diseases, Openflex Ltd

Sheela Upadhyaya | Life Science Advisor in Rare Diseases | Openflex Ltd » speaking at World EPA Congress

Caroline van der Meijden, Director, iMTA

Caroline van der Meijden | Director | iMTA » speaking at World EPA Congress

Oliver van Zon, VP Market Access Europe, Crinetics Pharmaceuticals

Oliver van Zon | VP Market Access Europe | Crinetics Pharmaceuticals » speaking at World EPA Congress

Yvette Venable, Global Senior Director of Payer Partnerships and Policy, AstraZeneca

Yvette Venable | Global Senior Director of Payer Partnerships and Policy | AstraZeneca » speaking at World EPA Congress

Rosa Maria Vivanco Hidalgo, Head of Health Technology Assessment, AQuAS Gencat

Rosa Maria Vivanco Hidalgo | Head of Health Technology Assessment | AQuAS Gencat » speaking at World EPA Congress

Reg Waldeck, Vice President, Head Global Market Access, Bayer

Reg Waldeck | Vice President, Head Global Market Access | Bayer » speaking at World EPA Congress

Billy West, Equitable Access Lead, Wellcome Trust

Billy West | Equitable Access Lead | Wellcome Trust » speaking at World EPA Congress

Keir Woods, Vice President, Global Value Demonstration, Market Access & Pricing (GVAP), Oncology, Merck Group

Keir Woods | Vice President, Global Value Demonstration, Market Access & Pricing (GVAP), Oncology | Merck Group » speaking at World EPA Congress

Get Involved 
 

Sponsorship & Exhibition Sales


Oliver Hersey-Swan
oliver.hersey-swan@terrapinn.com

Conference Production


Isla Sutherland
isla.sutherland@terrapinn.com
 

Marketing Opportunities


Hidy Lee
hidy.lee@terrapinn.com